5ht1 receptor agonists, caffeine and either a cox-2...

Details 5ht1 receptor agonists, caffeine and either a cox-2... 5ht1 receptor agonists, caffeine and either a cox-2...

A - Human Necessities

61

K

A61K 31/522 (2006.01) A61K 31/33 (2006.01) A61K 31/495 (2006.01) A61K 31/498 (2006.01) A61K 31/52 (2006.01) A61K 45/06 (2006.01) A61P 25/06 (2006.01) A61P 29/00 (2006.01) G01N 33/15 (2006.01) C12Q 1/02 (2006.01)

Patent

CA 2312631

Disclosed is a pharmaceutical composition for treating migraine in a mammal, including a human, which comprises (a) a 5HT1 receptor agonist, (b) caffeine and (c) either a cyclooxygenase-2 (COX-2) inhibitor or a nonsteroidal antiinflammatory drug (NSAID).

Affiliated with

Also associated with

Rating

5ht1 receptor agonists, caffeine and either a cox-2... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5ht1 receptor agonists, caffeine and either a cox-2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5ht1 receptor agonists, caffeine and either a cox-2... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1980362